FDA's Drug Review Process and the Package Label

Strategies for Writing Successful FDA Submissions

Nonfiction, Health & Well Being, Medical, Medical Science, Biotechnology, Business & Finance, Industries & Professions, Industries
Cover of the book FDA's Drug Review Process and the Package Label by Tom Brody, PhD, Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Tom Brody, PhD ISBN: 9780128146484
Publisher: Elsevier Science Publication: December 1, 2017
Imprint: Academic Press Language: English
Author: Tom Brody, PhD
ISBN: 9780128146484
Publisher: Elsevier Science
Publication: December 1, 2017
Imprint: Academic Press
Language: English

FDA's Drug Review Process and the Package Label provides guidance to pharmaceutical companies for writing FDA-submissions, such as the NDA, BLA, Clinical Study Reports, and Investigator's Brochures. The book provides guidance to medical writers for drafting FDA-submissions in a way more likely to persuade FDA reviewers to grant approval of the drug. In detail, the book reproduces data on efficacy and safety from one hundred different FDA-submissions (NDAs, BLAs). The book reproduces comments and complaints from FDA reviewers regarding data that are fragmentary, ambiguous, or that detract from the drug's approvability, and the book reveals how sponsors overcame FDA's concerns and how sponsors succeeded in persuading FDA to grant approval of the drug. The book uses the most reliable and comprehensive source of information available for writing FDA-submissions, namely text and data from NDAs and BLAs, as published on FDA's website. The source material for writing this book included about 80,000 pages from FDA's Medical Reviews, FDA's Clinical Pharmacology Reviews, and FDA's Pharmacology Reviews, from one hundred different NDAs or BLAs for one hundred different drugs. Each chapter focuses on a different section of the package label, e.g., the Dosage and Administration section or the Drug Interactions section, and demonstrates how the sponsor's data supported that section of the package label.

  • Reveals strategies for winning FDA approval and for drafting the package label
  • Examples are from one hundred FDA-submissions (NDAs, BLAs) for one hundred different drugs, e.g., for oncology, metabolic diseases, autoimmune diseases, and neurological diseases
  • This book uses the most reliable and comprehensive source of information available for writing FDA-submissions, namely, the data from NDAs and BLAs as published on FDA's website at the time FDA grants approval to the drug
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

FDA's Drug Review Process and the Package Label provides guidance to pharmaceutical companies for writing FDA-submissions, such as the NDA, BLA, Clinical Study Reports, and Investigator's Brochures. The book provides guidance to medical writers for drafting FDA-submissions in a way more likely to persuade FDA reviewers to grant approval of the drug. In detail, the book reproduces data on efficacy and safety from one hundred different FDA-submissions (NDAs, BLAs). The book reproduces comments and complaints from FDA reviewers regarding data that are fragmentary, ambiguous, or that detract from the drug's approvability, and the book reveals how sponsors overcame FDA's concerns and how sponsors succeeded in persuading FDA to grant approval of the drug. The book uses the most reliable and comprehensive source of information available for writing FDA-submissions, namely text and data from NDAs and BLAs, as published on FDA's website. The source material for writing this book included about 80,000 pages from FDA's Medical Reviews, FDA's Clinical Pharmacology Reviews, and FDA's Pharmacology Reviews, from one hundred different NDAs or BLAs for one hundred different drugs. Each chapter focuses on a different section of the package label, e.g., the Dosage and Administration section or the Drug Interactions section, and demonstrates how the sponsor's data supported that section of the package label.

More books from Elsevier Science

Cover of the book Skin Tissue Engineering and Regenerative Medicine by Tom Brody, PhD
Cover of the book Exploring Engineering by Tom Brody, PhD
Cover of the book Modelling Freight Transport by Tom Brody, PhD
Cover of the book Diabetes by Tom Brody, PhD
Cover of the book Neural Networks in Finance by Tom Brody, PhD
Cover of the book Thermophysical Properties of Chemicals and Hydrocarbons by Tom Brody, PhD
Cover of the book Complementarity and Variational Inequalities in Electronics by Tom Brody, PhD
Cover of the book Multi-Asset Risk Modeling by Tom Brody, PhD
Cover of the book Fish Physiology: Hypoxia by Tom Brody, PhD
Cover of the book Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders by Tom Brody, PhD
Cover of the book Subsea Pipeline Design, Analysis, and Installation by Tom Brody, PhD
Cover of the book Licensing Electronic Resources in Academic Libraries by Tom Brody, PhD
Cover of the book Advances in the Study of Behavior by Tom Brody, PhD
Cover of the book Principles of Colour and Appearance Measurement by Tom Brody, PhD
Cover of the book Job Hazard Analysis by Tom Brody, PhD
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy